Literature DB >> 9583821

Tissue engineering: a new approach in cardiovascular surgery: Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh.

G Zünd1, S P Hoerstrup, A Schoeberlein, M Lachat, G Uhlschmid, P R Vogt, M Turina.   

Abstract

OBJECTIVE: In tissue engineering the material properties of synthetic compounds are chosen to enable delivery of dissociated cells onto a scaffold in a manner that will result in in vitro formation of a new functional tissue. The seeding of human fibroblasts followed by human endothelial cells on resorbable mesh is a precondition of a successful creation of human tissues such as vessels or cardiac valves.
METHODS: Polymeric scaffolds (n = 18) composed of polyglycolic acid (PGA) with a fiber diameter of 12-15 microm and a polymer density of 70 mg/ml were used as square sheets of 1 x 1 x 0.3 cm. Fibroblasts (passage 7) harvested from human foreskin were seeded (3.4 x 10(6)) and cultured over a 3 week period on a PGA-mesh, followed by seeding of endothelial cells (passage 5, 2.8 x 10(6)) harvested from human ascending aorta. Thereafter the new tissue was stained for HE, van Gieson, Trichrom Masson, Factor VIII and CD 34 and proved by scanning electron microscopy.
RESULTS: Microscopic examination of the seeded mesh demonstrated that the human fibroblasts were attached to the polymeric fibers and had begun to spread out and divide. The scanning electron microscopic examination demonstrated a homogeneous scaffold resembling a solid sheet of tissue. The seeded endothelial cells formed a monolayer on the fibroblasts and no endothelial cell invasion or new formation of capillaris could be detected.
CONCLUSIONS: These results are a first step to demonstrate that seeding of human fibroblasts and endothelial cells on PGA-mesh might be a feasible model to construct human tissues such as vessels or cardiac valves.

Entities:  

Mesh:

Year:  1998        PMID: 9583821     DOI: 10.1016/s1010-7940(97)00309-6

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  8 in total

Review 1.  Heart valve and arterial tissue engineering.

Authors:  C E Sarraf; A B Harris; A D McCulloch; M Eastwood
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

Review 2.  Umbilical cord cells as a source of cardiovascular tissue engineering.

Authors:  Christian Breymann; Dörthe Schmidt; S P Hoerstrup
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 3.  Tissue engineering on matrix: future of autologous tissue replacement.

Authors:  Benedikt Weber; Maximilian Y Emmert; Roman Schoenauer; Chad Brokopp; Laura Baumgartner; Simon P Hoerstrup
Journal:  Semin Immunopathol       Date:  2011-01-29       Impact factor: 9.623

Review 4.  [Tissue engineering for heart valves and vascular grafts].

Authors:  O E Teebken; M Wilhelmi; A Haverich
Journal:  Chirurg       Date:  2005-05       Impact factor: 0.955

5.  Self-assembling biomaterials: liquid crystal phases of cholesteryl oligo(L-lactic acid) and their interactions with cells.

Authors:  Julia J Hwang; Subramani N Iyer; Li-Sheng Li; Randal Claussen; Daniel A Harrington; Samuel I Stupp
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

6.  Carbon nanotubes reinforced chitosan films: mechanical properties and cell response of a novel biomaterial for cardiovascular tissue engineering.

Authors:  A Kroustalli; A E Zisimopoulou; S Koch; L Rongen; D Deligianni; S Diamantouros; G Athanassiou; M Kokozidou; D Mavrilas; S Jockenhoevel
Journal:  J Mater Sci Mater Med       Date:  2013-08-25       Impact factor: 3.896

7.  Scaffold Sheet Design Strategy for Soft Tissue Engineering.

Authors:  Richard T Tran; Paul Thevenot; Yi Zhang; Dipendra Gyawali; Liping Tang; Jian Yang
Journal:  Nat Mater       Date:  2010-02-24       Impact factor: 43.841

8.  A Tubular Biomaterial Construct Exhibiting a Negative Poisson's Ratio.

Authors:  Jin Woo Lee; Pranav Soman; Jeong Hun Park; Shaochen Chen; Dong-Woo Cho
Journal:  PLoS One       Date:  2016-05-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.